{
  "gene": "FH",
  "phenotype_entities": [
    {"name": "Fumarase deficiency", "source_mentions": ["OMIM", "GENEREVIEWS"]},
    {"name": "Fumaric aciduria", "source_mentions": ["ORPHANET"]},
    {"name": "Hereditary leiomyomatosis and renal cell cancer", "source_mentions": ["OMIM", "ORPHANET", "GENEREVIEWS"]},
    {"name": "Hereditary pheochromocytoma-paraganglioma", "source_mentions": ["ORPHANET"]}
  ],
  "criteria_reasoning": {
    "assertions_made": {
      "verdict": "Multiple entities",
      "justification": "OMIM lists two distinct phenotypes with different inheritance: Fumarase deficiency (AR) and HLRCC (AD). Orphanet additionally lists hereditary pheochromocytoma-paraganglioma as a separate disease and uses the label fumaric aciduria for the AR condition."
    },
    "molecular_mechanism": {
      "verdict": "Shared",
      "justification": "Both AR fumarase deficiency and AD HLRCC involve loss of FH enzymatic function (biallelic deficiency in AR; tumor suppressor with reduced activity and biallelic inactivation in tumors for AD). Despite shared LOF, disease biology and clinical context differ (metabolic encephalopathy vs tumor predisposition)."
    },
    "phenotypic_variability": {
      "verdict": "Distinct phenotypes",
      "justification": "AR disease is a severe neurodevelopmental/encephalopathic disorder, whereas AD HLRCC is a tumor predisposition syndrome with leiomyomas and renal cell carcinoma. Variability within HLRCC exists, but is within a tumor spectrum and distinct from the AR presentation."
    },
    "mode_of_inheritance": {
      "verdict": "Different",
      "justification": "Fumarase deficiency/fumaric aciduria is autosomal recessive; HLRCC is autosomal dominant. Orphanet lists FH for hereditary pheochromocytoma-paraganglioma but MOI is not specified in the provided text."
    }
  },
  "entity_decisions": [
    {"name": "Fumarase deficiency", "decision": "LUMP", "confidence": 0.9},
    {"name": "Fumaric aciduria", "decision": "LUMP", "confidence": 0.9},
    {"name": "Hereditary leiomyomatosis and renal cell cancer", "decision": "SPLIT", "confidence": 0.95},
    {"name": "Hereditary pheochromocytoma-paraganglioma", "decision": "Unclear", "confidence": 0.5}
  ],
  "proposed_groupings": [
    {
      "group_id": 1,
      "entities": ["Fumarase deficiency", "Fumaric aciduria"],
      "proposed_label": "Fumarate hydratase deficiency",
      "mode_of_inheritance": "Autosomal recessive",
      "criteria_met": ["assertions", "molecular_mechanism", "mode_of_inheritance"],
      "reasoning": "OMIM and GeneReviews describe AR FH deficiency; Orphanet’s 'Fumaric aciduria' refers to the same AR LOF condition. Shared mechanism and management justify lumping.",
      "decision": "LUMP"
    },
    {
      "group_id": 2,
      "entities": ["Hereditary leiomyomatosis and renal cell cancer"],
      "proposed_label": "Hereditary leiomyomatosis and renal cell cancer",
      "mode_of_inheritance": "Autosomal dominant",
      "criteria_met": ["assertions", "phenotypic_variability", "mode_of_inheritance"],
      "reasoning": "Consistently asserted as a distinct AD tumor predisposition syndrome with different phenotype and clinical management from AR FH deficiency.",
      "decision": "SPLIT"
    }
  ],
  "overall_decision": {
    "verdict": "SPLIT",
    "summary_reasoning": "Authoritative sources consistently present two main FH-related entities: AR fumarase deficiency/fumaric aciduria and AD HLRCC. Despite shared LOF at the gene level, they differ in inheritance, clinical presentation, and management. Orphanet additionally lists hereditary pheochromocytoma-paraganglioma for FH, but corroboration in OMIM/GeneReviews is absent in this bundle, so its relationship to HLRCC remains unclear.",
    "confidence": 0.88
  },
  "top_supporting_evidence": [
    "OMIM: Gene-Phenotype Relationships – 'Fumarase deficiency 606812 AR' and 'Leiomyomatosis and renal cell cancer 150800 AD'",
    "GeneReviews: 'Fumarate hydratase (FH) deficiency results in severe neonatal and early infantile encephalopathy...' and 'Heterozygotes are at risk of developing hereditary leiomyomatosis and renal cell cancer.'",
    "Orphanet (FH page): 'Disease-causing germline mutation(s) in Hereditary leiomyomatosis and renal cell cancer ORPHA:523' and '... (loss of function) in Fumaric aciduria ORPHA:24' and '... in Hereditary pheochromocytoma-paraganglioma ORPHA:29072'"
  ],
  "suggested_action_for_curator": [
    "Verify whether FH-associated hereditary pheochromocytoma-paraganglioma should be considered part of HLRCC spectrum or a separate FH-related entity based on additional sources.",
    "Confirm mode of inheritance and clinical management distinctions for any FH-related pheochromocytoma/paraganglioma cases."
  ]
}